Dr. Glenn J. Hanna, MD
Claim this profileDana Farber Cancer Institute
Studies Squamous Cell Carcinoma
Studies Cancer
22 reported clinical trials
40 drugs studied
Area of expertise
1Squamous Cell Carcinoma
Stage IV
HPV positive
HPV negative
2Cancer
Stage IV
HPV positive
HPV negative
Affiliated Hospitals
Clinical Trials Glenn J. Hanna, MD is currently running
Ivonescimab
for Salivary Gland Cancer
The goal of this study is to evaluate the efficacy and safety of Ivonescimab in participants with advanced, metastatic salivary gland cancers. The name of the study drug involved in this study is: -Ivonescimab (a type of antibody)
Recruiting1 award Phase 23 criteria
T-DM1 + Chemoradiation
for Salivary Gland Cancer
This trial is testing a special drug called T-DM1 combined with regular cancer treatments in patients with HER2-positive salivary gland cancer. The drug targets cancer cells specifically and delivers chemotherapy directly to them. The goal is to see if this combination is safe and effective in preventing cancer recurrence. T-DM1 has shown effectiveness in treating HER2-positive cancers, including breast and salivary gland cancers, by targeting cancer cells and delivering chemotherapy directly to them.
Recruiting1 award Phase 221 criteria
More about Glenn J. Hanna, MD
Clinical Trial Related1 year of experience running clinical trials · Led 22 trials as a Principal Investigator · 10 Active Clinical TrialsTreatments Glenn J. Hanna, MD has experience with
- Nivolumab
- Ipilimumab
- Cetuximab
- RP2
- Lirilumab
- Surgery
Breakdown of trials Glenn J. Hanna, MD has run
Squamous Cell Carcinoma
Cancer
Adenoid Cystic Carcinoma
Salivary Gland Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Glenn J. Hanna, MD specialize in?
Glenn J. Hanna, MD focuses on Squamous Cell Carcinoma and Cancer. In particular, much of their work with Squamous Cell Carcinoma has involved Stage IV patients, or patients who are HPV positive.
Is Glenn J. Hanna, MD currently recruiting for clinical trials?
Yes, Glenn J. Hanna, MD is currently recruiting for 10 clinical trials in Boston Massachusetts. If you're interested in participating, you should apply.
Are there any treatments that Glenn J. Hanna, MD has studied deeply?
Yes, Glenn J. Hanna, MD has studied treatments such as Nivolumab, Ipilimumab, Cetuximab.
What is the best way to schedule an appointment with Glenn J. Hanna, MD?
Apply for one of the trials that Glenn J. Hanna, MD is conducting.
What is the office address of Glenn J. Hanna, MD?
The office of Glenn J. Hanna, MD is located at: Dana Farber Cancer Institute, Boston, Massachusetts 02215 United States. This is the address for their practice at the Dana Farber Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.